Association of Parental HLA-G Polymorphisms with Soluble HLA-G Expressions and Their Roles on Recurrent Implantation Failure: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Introduction: HLA-G plays a central role in immune tolerance at the maternal-fetal interface. The HLA-G gene is characterized by low allelic polymorphism and restricted tissue expression compared with classical HLA genes. HLA-G polymorphism is associated with HLA-G expression and linked to pregnancy complications. However, the association of parental HLA-G polymorphisms with soluble HLA-G (sHLA-G) expression and their roles in recurrent implantation failure (RIF) is unclear. The study aims to systematically review the association of HLA-G polymorphisms with RIF, the association of sHLA-G expression with RIF, and the association of HLA-G polymorphisms with sHLA-G expressions in patients attending fertilization (IVF) treatment.
Methods: Studies that evaluated the association of HLA-G polymorphisms with RIF, the association between sHLA-G expression with RIF, and the association between HLA-G polymorphisms with sHLA-G expressions in patients attending IVF treatment were included. Meta-analysis was performed by random-effect models. Sensitivity analysis was performed by excluding one study each time. Subgroup analysis was performed based on ethnicity.
Results: HLA-G 14bp ins variant is associated with a lower expression of sHLA-G in seminal or blood plasma of couples attending IVF treatment. The maternal HLA-G*010101 and paternal HLA-G*010102 alleles are associated with RIF risk compared to other alleles. However, single maternal HLA-G 14bp ins/del polymorphism, HLA-G -725 C>G/T polymorphism, or circulating sHLA-G concentration was not significantly associated with RIF in the general population. HLA-G 14bp ins/ins homozygous genotype or ins variant was associated with a higher risk of RIF in the Caucasian population.
Discussion: Specific HLA-G alleles or HLA-G polymorphisms are associated with sHLA-G expression in couples attending IVF treatment. Several HLA-G polymorphisms may be related to RIF, considering different ethnic backgrounds. A combined genetic effect should be considered in future studies to confirm the association of HLA-G polymorphisms and sHLA-G expressions in relation to RIF.
Garmendia J, De Sanctis C, Hajduch M, De Sanctis J Int J Mol Sci. 2025; 26(3).
PMID: 39941063 PMC: 11818386. DOI: 10.3390/ijms26031295.
Uta C, Tirziu A, Zimbru E, Zimbru R, Georgescu M, Haidar L Medicina (Kaunas). 2024; 60(11).
PMID: 39597081 PMC: 11596804. DOI: 10.3390/medicina60111896.
Xu D, Zhu Y, Wang J, Guan H, Shen X Hum Genomics. 2024; 18(1):126.
PMID: 39551809 PMC: 11572094. DOI: 10.1186/s40246-024-00695-5.
Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy.
Toadere T, tichindeleanu A, Bondor D, Topor I, Trella S, Nenu I Inflamm Res. 2024; 73(5):793-807.
PMID: 38492049 DOI: 10.1007/s00011-024-01866-9.
HLA-G and Recurrent Pregnancy Loss.
Barbaro G, Inversetti A, Cristodoro M, Ticconi C, Scambia G, Di Simone N Int J Mol Sci. 2023; 24(3).
PMID: 36768880 PMC: 9917226. DOI: 10.3390/ijms24032557.